Total Payments
$10,972
2024 Payments
$1,139
Companies
45
Transactions
859
Medicare Patients
9,399
Medicare Billing
$473,607
Payment Breakdown by Category
Food & Beverage$10,943 (99.7%)
Education$29.05 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,943 | 854 | 99.7% |
| Education | $29.05 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,064 | 121 | $0 (2024) |
| Novo Nordisk Inc | $1,028 | 92 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $802.62 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $771.59 | 69 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $758.69 | 55 | $0 (2024) |
| Lilly USA, LLC | $705.67 | 60 | $0 (2024) |
| ABBVIE INC. | $650.98 | 47 | $0 (2024) |
| Merck Sharp & Dohme LLC | $622.15 | 58 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $620.30 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $497.66 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,139 | 72 | Bayer Healthcare Pharmaceuticals Inc. ($206.50) |
| 2023 | $984.37 | 71 | Novo Nordisk Inc ($173.42) |
| 2022 | $1,632 | 117 | Novo Nordisk Inc ($265.65) |
| 2021 | $1,787 | 127 | AbbVie Inc. ($276.85) |
| 2020 | $963.70 | 69 | Novo Nordisk Inc ($132.25) |
| 2019 | $1,281 | 111 | PFIZER INC. ($268.93) |
| 2018 | $1,398 | 123 | PFIZER INC. ($285.08) |
| 2017 | $1,787 | 169 | Merck Sharp & Dohme Corporation ($255.56) |
All Payment Transactions
859 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Hematology | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Bone Health | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,051 | 4,693 | $214,257 | $111,069 |
| 2022 | 38 | 2,444 | 5,256 | $240,313 | $119,470 |
| 2021 | 35 | 2,398 | 5,260 | $234,170 | $118,659 |
| 2020 | 34 | 2,506 | 5,644 | $257,355 | $124,409 |
Total Patients
9,399
Total Services
20,853
Medicare Billing
$473,607
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 406 | $62,524 | $31,846 | 50.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,500 | $37,440 | $27,570 | 73.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 150 | $16,300 | $7,607 | 46.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 63 | 63 | $4,914 | $4,700 | 95.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 181 | 305 | $13,725 | $4,002 | 29.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 86 | $5,590 | $3,972 | 71.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 157 | 240 | $10,080 | $3,950 | 39.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 197 | 332 | $13,280 | $3,436 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 383 | $3,830 | $3,217 | 84.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 188 | 303 | $6,363 | $2,306 | 36.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $3,740 | $2,234 | 59.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $3,640 | $2,098 | 57.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 154 | 237 | $8,295 | $2,095 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 65 | $2,340 | $1,824 | 77.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 109 | 176 | $3,696 | $1,676 | 45.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 48 | $2,400 | $1,671 | 69.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 16 | $2,400 | $1,429 | 59.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 23 | $2,300 | $1,366 | 59.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 19 | $1,520 | $726.18 | 47.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 16 | 18 | $900.00 | $522.18 | 58.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 17 | $1,020 | $480.48 | 47.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 23 | 24 | $960.00 | $432.48 | 45.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 44 | $1,584 | $392.54 | 24.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 25 | $1,125 | $309.70 | 27.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 19 | 20 | $600.00 | $295.60 | 49.3% |
About Dr. William Kleinschrodt, M.D
Dr. William Kleinschrodt, M.D is a Internal Medicine healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396786836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Kleinschrodt, M.D has received a total of $10,972 in payments from pharmaceutical and medical device companies, with $1,139 received in 2024. These payments were reported across 859 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($10,943).
As a Medicare-enrolled provider, Kleinschrodt has provided services to 9,399 Medicare beneficiaries, totaling 20,853 services with total Medicare billing of $473,607. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Mobile, AL
- Active Since 06/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396786836
Products in Payments
- ENTRESTO (Drug) $728.84
- XARELTO (Drug) $610.93
- Ozempic (Drug) $572.25
- Kerendia (Drug) $481.32
- CUVITRU (Biological) $408.04
- UBRELVY (Drug) $407.39
- FARXIGA (Drug) $402.39
- JANUVIA (Drug) $378.58
- CHANTIX (Drug) $366.65
- XIFAXAN (Drug) $328.41
- Rybelsus (Drug) $309.17
- TRULICITY (Drug) $308.22
- ELIQUIS (Drug) $297.02
- TRELEGY ELLIPTA (Drug) $283.20
- BEVESPI AEROSPHERE (Drug) $173.53
- LINZESS (Drug) $168.96
- SOLIQUA 100/33 (Biological) $167.17
- TOUJEO (Drug) $153.83
- BREZTRI (Drug) $150.08
- BASAGLAR (Drug) $146.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mobile
Phillip Henderson, D.o, D.O
Internal Medicine — Payments: $581,808
Internal Medicine $581,808
Thomas Mckelvey, Md, MD
Internal Medicine — Payments: $525,947
Internal Medicine $525,947
Dr. Mary Honkanen, Md, MD
Internal Medicine — Payments: $479,092
Internal Medicine $479,092
Bobby Wrights, Md, MD
Internal Medicine — Payments: $126,247
Internal Medicine $126,247
Dr. Rahel Aziz, Md, MD
Internal Medicine — Payments: $39,226
Internal Medicine $39,226
Dr. Wilburn Bolton, M.d, M.D
Internal Medicine — Payments: $36,214
Internal Medicine $36,214